UK gets social media presence

Share this article:
The UK's Prescription Medicines Code of Practice Authority, which arbitrates drug industry self-regulation there, issued “informal guidance” on digital communications, and while it's more than FDA has offered, it's not much to go on.
The guidance, which takes the form of a Q&A, is mainly an interpretation of the industry's Code of Practice applied to social media and the internet. Short version: as in any other medium, companies can communicate only non-promotional information about products to the public, and only in response to a direct inquiry. However, the guidance does suggest that companies could post more basic product info on their websites.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.